Chediak-Higashi syndrome (Review of literature and clinical case reports)

Cover Page

Cite item

Full Text

Abstract

Chediak-Higashi syndrome (CHS) is a rare autosomal recessive immunodeficiency, caused by mutation in LYST-CHS1 gene, encoding the respective protein regulating the lysosomal transport. The syndrome is characterized by early onset, specific clinical features and laboratory signs (oculocutaneous albinism, the presence of peroxidase-positive giant granules in granule containing cells), a high risk of hemophagocytic lymphohistiocytosis (accelerated phase), and is fatal in the majority of cases. Hematopoietic stem cell transplantation (HSCT) is the only curative treatment. The best results of overall survival of CHS patients are attained if HSCT is carried out before the accelerated phase and with the use of reduced intensity conditioning. The authors present the experience gained in the diagnosis and treatment of three patients with CHS of different severity and with complications of the underlying disease. Two patients received HSCT with reduced intensity conditioning in accordance with the international recommendations. The results of catamnesis (duration of follow-up 4 months and 1 year) indicated complete hematological reconstitution.

About the authors

Yuliya A. Rodina

Federal Research Center of Pediatric Hematology, Oncology, and Immunology named after Dmitry Rogachev

Author for correspondence.
Email: rodina.julija@rambler.ru
Russian Federation

Victor E. Matveev

Federal Research Center of Pediatric Hematology, Oncology, and Immunology named after Dmitry Rogachev

Email: matveev-v.e@yandex.ru
Russian Federation

Dmitry N. Balashov

Federal Research Center of Pediatric Hematology, Oncology, and Immunology named after Dmitry Rogachev

Email: bala8@yandex.ru
Russian Federation

Maria E. Dubrovina

Federal Research Center of Pediatric Hematology, Oncology, and Immunology named after Dmitry Rogachev

Email: dubm@inbox.ru
Russian Federation

Anna Yu. Shcherbina

Federal Research Center of Pediatric Hematology, Oncology, and Immunology named after Dmitry Rogachev

Email: shcher26@hotmail.com
Russian Federation

References

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2016 Rodina Y.A., Matveev V.E., Balashov D.N., Dubrovina M.E., Shcherbina A.Y.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.